Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AD
- Chemical substanceB01AD11Tenecteplase
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 3 registrations
- Metalyse 10.000 Unidades (50 MG) Polvo y Disolvente Para Solucion Inyectable1000 U · polvo y disolvente para solución inyectable · Boehringer Ingelheim International Gmbh
- Metalyse 5.000 Unidades (25 MG) Polvo Para Solucion Inyectable25 mg · polvo para solución inyectable · Boehringer Ingelheim International Gmbh
- Metalyse 8.000 Unidades (40 MG) Polvo y Disolvente Para Solucion Inyectable1000 U · polvo y disolvente para solución inyectable · Boehringer Ingelheim International Gmbh
Netherlands
CBG-MEB · 3 registrations
At a glance
- ATC code
- B01AD11
- ATC group
- Blood and blood-forming organs
- Registers
- 10
- Historical lists
- 2
- Registrations
- 23
- With their own page
- 19
- Companies
- 7
All medicines with Tenecteplase
Human medicines from every register that match Tenecteplase by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
23 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tnkase | United States | 50MG/VIAL | vial | Marketed | Genentech |
| TNKase | United States | 25MG | For Injection | Marketed | Genentech, Inc. |
| Tnkase | Canada | 25 MG / VIAL | Powder For Solution | Marketed | Hoffmann-LA Roche Limited |
| Tnkase | Canada | 50 MG / VIAL | Powder For Solution | Marketed | Hoffmann-LA Roche Limited |
| Metalyse | European Union | Authorised | Boehringer Ingelheim International GmbH | ||
| Metalyse 5.000 Unidades (25 MG) Polvo Para Solucion Inyectable | Spain | 25 mg | polvo para solución inyectable | Marketed | Boehringer Ingelheim International Gmbh |
| Metalyse 8.000 Unidades (40 MG) Polvo y Disolvente Para Solucion Inyectable | Spain | 1000 U | polvo y disolvente para solución inyectable | Marketed | Boehringer Ingelheim International Gmbh |
| Metalyse 10.000 Unidades (50 MG) Polvo y Disolvente Para Solucion Inyectable | Spain | 1000 U | polvo y disolvente para solución inyectable | Marketed | Boehringer Ingelheim International Gmbh |
| Metalyse 5.000 units, poeder voor oplossing voor injectie | Netherlands | Poeder voor oplossing voor injectie | Authorised | Boehringer Ingelheim International GmbH | |
| Metalyse 8.000 units, poeder en oplosmiddel voor oplossing voor injectie | Netherlands | Poeder en oplosmiddel voor oplossing voor injectie | Authorised | Boehringer Ingelheim International GmbH | |
| Metalyse 10.000 units, poeder en oplosmiddel voor oplossing voor injectie | Netherlands | Poeder en oplosmiddel voor oplossing voor injectie | Authorised | Boehringer Ingelheim International GmbH | |
| Metalyse | Brazil | Authorised | Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. | ||
| Metalyse® | Serbia | 5000jedinica | prašak za rastvor za injekciju | Authorised | Boehringer Ingelheim Serbia D.O.O. Beograd |
| Metalyse® | Serbia | 50mg/10mL | prašak i rastvarač za rastvor za injekciju | Authorised | Boehringer Ingelheim Serbia D.O.O. Beograd |
| METALYSE FOR INJECTION 5,000 u/vial | Singapore | 5,000 units (25 mg)/vial | injection, powder, for solution | Authorised | Boehringer Ingelheim Singapore Pte. LTD. |
| METALYSE FOR INJECTION 10,000 u/vial | Singapore | 10000 u/vial | injection, powder, for solution | Authorised | Boehringer Ingelheim Singapore Pte. LTD. |
| Metalyse | Croatia | Marketed | |||
| Metalyse | New Zealand | Inj 50 mg per vial with diluent | Funded | ||
| Metalyse | New Zealand | Inj 50 mg vial with diluent | Funded | ||
| Metalyse 10000 U I.V Vial | Saudi Arabia | Authorised | Boehringer Ingelheim | ||
| Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG | European Union | Withdrawn | Boehringer Ingelheim International GmbH | ||
| Metalyse 10000 U | Romania | 5mg/ml (1000 U/ml | pulb. + solv. pt. sol. inj. | Status unknown | Boehringer Ingelheim International GMBH |
| Metalyse 8000 U | Romania | 5mg/ml (1000 U/ml | pulb. + solv. pt. sol. inj. | Status unknown | Boehringer Ingelheim International GMBH |